Alerts will be sent to your verified email
Verify Email
ALEMBICLTD
|
Alembic
|
Equinox India Dev.
|
Man InfraConstruct
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
10.3 % | n/a | n/a |
|
R&D as a % of Total Sales
|
0.52 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
14.77 % | -0.9 % | 11.72 % |
|
5yr average Equity Multiplier
|
1.05 | 2.69 | 1.88 |
|
5yr Average Asset Turnover Ratio
|
0.05 | 0.22 | 0.49 |
|
5yr Avg Net Profit Margin
|
303.48 % | -19.79 % | 10.45 % |
|
Price to Book
|
1.36 | 3.52 | 4.97 |
|
P/E
|
11.08 | 0.0 | 24.24 |
|
5yr Avg Cash Conversion Cycle
|
144.48 Days | 3107.28 Days | 50.2 Days |
|
Inventory Days
|
215.64 Days | 1602.08 Days | 289.1 Days |
|
Days Receivable
|
55.47 Days | 108.68 Days | 44.22 Days |
|
Days Payable
|
278.49 Days | 128.33 Days | 249.54 Days |
|
5yr Average Interest Coverage Ratio
|
204.05 | -2.54 | 3.97 |
|
5yr Avg ROCE
|
3.89 % | 7.4 % | 19.83 % |
|
5yr Avg Operating Profit Margin
|
82.44 % | 0.31 % | 28.88 % |
|
5 yr average Debt to Equity
|
0.0 | 0.59 | 0.57 |
|
5yr CAGR Net Profit
|
-2.2 % | n/a | 43.98 % |
|
5yr Average Return on Assets
|
14.11 % | -1.37 % | 6.56 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.88 % | 0.0 | 67.31 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -11.99 % | 1.59 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-4.29 % | -1.63 % | 2.1 % |
|
Alembic
|
Equinox India Dev.
|
Man InfraConstruct
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
Operating Profit Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|